Cargando…

Emerging trends in inhaled drug delivery

Ideally, inhaled therapy is driven by the needs of specific disease management. Lung biology interfaces with inhaler performance to allow optimal delivery of therapeutic agent for disease treatment. Inhalation aerosol products consist of the therapeutic agent, formulation, and device. The manufactur...

Descripción completa

Detalles Bibliográficos
Autor principal:	Hickey, Anthony J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier B.V. 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7354278/ https://www.ncbi.nlm.nih.gov/pubmed/32663488 http://dx.doi.org/10.1016/j.addr.2020.07.006

Ejemplares similares

Targeting Drug Delivery to the Lungs by Inhalation
por: O'Callaghan, C.
Publicado: (1994)

Inhaled nano- and microparticles for drug delivery
por: El-Sherbiny, Ibrahim M., et al.
Publicado: (2015)

Inhalation drug delivery devices: technology update
por: Ibrahim, Mariam, et al.
Publicado: (2015)

Inhaled antibodies: Quality and performance considerations
por: Hickey, Anthony James, et al.
Publicado: (2021)

Unraveling the pulmonary drug delivery carriers in inhalable nanostructures
por: Huang, Zhengwei, et al.
Publicado: (2022)

Advances in Pulmonary Drug Delivery Systems and Inhalation Formulations
por: Lam, Jenny K. W., et al.
Publicado: (2023)

Emerging Trends in Noninvasive Insulin Delivery
por: Verma, Arun, et al.
Publicado: (2014)

Effect of Inhalation Profile on Delivery of Treprostinil Palmitil Inhalation Powder
por: Gauani, Helena, et al.
Publicado: (2023)

Inhalable Nanoparticles/Microparticles of an AMPK and Nrf2 Activator for Targeted Pulmonary Drug Delivery as Dry Powder Inhalers
por: Acosta, Maria F., et al.
Publicado: (2020)

Aggregated Nanotransfersomal Dry Powder Inhalation of Itraconazole for Pulmonary Drug Delivery
por: Hassanpour Aghdam, Mehdi, et al.
Publicado: (2016)

The Respimat(®) Soft Mist Inhaler: Implications of Drug Delivery Characteristics for Patients
por: Iwanaga, Takashi, et al.
Publicado: (2019)

Mechanisms by Which Liposomes Improve Inhaled Drug Delivery for Alveolar Diseases
por: Ferguson, Laura T., et al.
Publicado: (2023)

The topical study of inhaled drug (salbutamol) delivery in idiopathic pulmonary fibrosis
por: Usmani, Omar S., et al.
Publicado: (2018)

An Update on Advancements and Challenges in Inhalational Drug Delivery for Pulmonary Arterial Hypertension
por: Agnihotri, Vinit, et al.
Publicado: (2022)

Therapeutic Use of an Inhaled Drug Delivery in Pulmonary Hypertension: A Review
por: Kumbhare, Unnati, et al.
Publicado: (2022)

Liposomal Forms of Fluoroquinolones and Antifibrotics Decorated with Mannosylated Chitosan for Inhalation Drug Delivery
por: Le-Deygen, Irina, et al.
Publicado: (2023)

Dry Powder Inhalers: A Focus on Advancements in Novel Drug Delivery Systems
por: Mehta, Piyush
Publicado: (2016)

Hierarchical pulmonary target nanoparticles via inhaled administration for anticancer drug delivery
por: Chen, Rui, et al.
Publicado: (2017)

In vitro efficiency of Amikacin Inhale, a novel drug-device delivery system
por: Kadrichu, N, et al.
Publicado: (2013)

Inhalable microparticles as drug delivery systems to the lungs in a dry powder formulations
por: Knap, Karolina, et al.
Publicado: (2022)

Flow Patterns and Particle Residence Times in the Oral Cavity during Inhaled Drug Delivery
por: Vara Almirall, Brenda, et al.
Publicado: (2022)

A Critical Review on Emerging Trends in Dry Powder Inhaler Formulation for the Treatment of Pulmonary Aspergillosis
por: Cheng, Shen Nam, et al.
Publicado: (2020)

Oligonucleotide Delivery to the Lung: Waiting to Inhale
por: Kjems, Jørgen, et al.
Publicado: (2012)

Nanomedicine: Revolutionary trends in drug delivery and diagnostics
por: Nagaich, Upendra
Publicado: (2014)

Publication Trends in Drug Delivery and Magnetic Nanoparticles
por: Ale Ebrahim, Saba, et al.
Publicado: (2019)

Inhaled Liposomal Antimicrobial Delivery in Lung Infections
por: Bassetti, Matteo, et al.
Publicado: (2020)

Nanotechnology-Assisted Metered-Dose Inhalers (MDIs) for High-Performance Pulmonary Drug Delivery Applications
por: Kumar, Raj, et al.
Publicado: (2022)

Inhalation therapies in COPD — adverse drug reactions impact on emergency department presentations
por: Bergs, Ingmar, et al.
Publicado: (2022)

Nanoparticles that do not adhere to mucus provide uniform and long-lasting drug delivery to airways following inhalation
por: Schneider, Craig S., et al.
Publicado: (2017)

Current trends in polymer microneedle for transdermal drug delivery
por: Ahmed Saeed AL-Japairai, Khater, et al.
Publicado: (2020)

Orodispersible tablets: A new trend in drug delivery
por: Dey, Paramita, et al.
Publicado: (2010)

Microneedle for transdermal drug delivery: current trends and fabrication
por: Jung, Jae Hwan, et al.
Publicado: (2021)

Current Trends in Gelatin-Based Drug Delivery Systems
por: Milano, Francesca, et al.
Publicado: (2023)

Inhaled nitric oxide, methemoglobinemia, and route of delivery
por: Raut, Monish S., et al.
Publicado: (2017)

Lipid Nanoparticles as Delivery Vehicles for Inhaled Therapeutics
por: Leong, Ellenmae W. X., et al.
Publicado: (2022)

Dry powder cationic lipopolymeric nanomicelle inhalation for targeted delivery of antitubercular drug to alveolar macrophage
por: Vadakkan, Mithun Varghese, et al.
Publicado: (2013)

iBCS: 2. Mechanistic Modeling of Pulmonary Availability of Inhaled Drugs versus Critical Product Attributes
por: Bäckman, Per, et al.
Publicado: (2022)

Self-sealing MEMS spray-nozzles to prevent bacterial contamination of portable inhalers for aqueous drug delivery
por: Last, Torben S., et al.
Publicado: (2022)

Inhaling muscle spray: A rising trend of abuse
por: Pothiawala, Sohil, et al.
Publicado: (2021)

Inhalation delivery technology for genome-editing of respiratory diseases
por: Chow, Michael Y.T., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_paiqusgb92afd5k034tlh12eer